A 16-year-old, previously healthy, female presented with a 1-week history of sore throat, fever, vomiting, and occipital headache. She also complained of generalized myalgia and lower limb weakness. There was no medication or substance use. Her immunizations were up to date, and she had no recent travel history or contact with persons from overseas. Examination in emergency revealed an unwell girl with nuchal rigidity and generalized hyperesthesia. Muscle strength in the lower extremities was graded 3-/5. In the upper extremities, strength was graded 4+/5 except distally on the right side, which was graded 4-/5 with scooping fingers and difficulty with extension of fingers, along with weak wrist flexion. Sitting was noted to be difficult. Reflexes were decreased in the lower limbs; brisk reflexes were found in the upper limbs.
Initial magnetic resonance imaging (MRI) showed extensive T2 signal changes throughout the spinal cord (Figure 1A,B). MRI of the brain did not reveal any significant intracranial abnormality. Initial differential diagnosis included demyelinating myelitis from an infectious, postinfectious, or inflammatory process. Infarction and neoplastic infiltration of the spinal cord were also considered. Her cerebrospinal fluid (CSF) had increased protein (2.29 g/L), lactate (4.2 mmol/L), cell count 840×106/L (neutrophils, 39; lymphocytes, 53; monocytes/macrophages, 8) and normal glucose (2.5 mmol/L). A CSF Gram stain revealed gram-negative diplococci versus coccobacilli (orientation of organism unclear). Blood and CSF cultures were obtained before treatment with intravenous cefotaxime and vancomycin at meningitic doses and dexamethasone (7.5 mg every 6 hours).
Overnight, she developed progressive flaccid paralysis of extremities; cefotaxime was switched to ceftriaxone and dexamethasone was switched to daily methylprednisone (1 g for 5 days) followed by oral prednisone (1 g/kg) in tapering doses over 20 days. She demonstrated gradual improvement of her extremity weakness. Repeat MRI showed minimal interval improvement (Figure 2). CSF and blood cultures yielded negative results, as did CFS analysis using 16S RNA PCR.Reference Edwards, Rogall, Blöcker, Emde and Böttger 1 CFS, stool, and nasopharyngeal secretion viral cultures (including polio virus) revealed no causative organism. She was treated with 14 days of antibiotics for presumed bacterial meningitis resulting from either Neisseria meningitidis or Haemophilus influenzae, based on the initial CSF Gram stain. Follow-up MRI 1 month after presentation revealed improvements, with minor residual inflammation/demyelination seen within the cervical/thoracic spinal cord (Figure 3). Two months after her presentation, she was ambulating with cane assistance. A repeat MRI 9 months after presentation showed resolution of abnormal findings. Follow-up 11 months after presentation showed almost complete neurological recovery, with only mild residual bowel and bladder dysfunction.
Comment
Meningitis presenting with diffuse myelopathy is rare. Proposed mechanisms of spinal cord damage include infarction, autoimmune-mediated infectious/postinfectious inflammatory myelopathy, direct infection, vasculitis, and hypoxia.Reference Khan, Altafullah and Ishaq 2 - Reference Rathore, Gill and Malik 6 , Reference Kastenbauer, Winkler, Fesl, Schiel, Ostermann and Yousry 8
Myelitis, an inflammation of the spinal cord, is a rare complication of meningococcal meningitis that usually occurs during treatment or as a late complication.Reference Khan, Altafullah and Ishaq 2 - Reference Kastenbauer, Winkler, Fesl, Schiel, Ostermann and Yousry 8 The thoracic cord and conus medullaris are most commonly affected.Reference Bhojo, Akhter, Bakshi and Wasay 4 Symptoms may evolve over hours or days, with lower extremity flaccidity, bowel and bladder dysfunction, and a reduced sensory level.Reference Roos 7 Reported MRI findings include intramedullary signal on T2-weighted images, cord swelling, leptomeningeal and intramedullary contrast enhancement.Reference Bhojo, Akhter, Bakshi and Wasay 4 - Reference Choudhary, Kumar, Ahlawat, Kapil, Yasir and Gaurav 5 , Reference Kastenbauer, Winkler, Fesl, Schiel, Ostermann and Yousry 8 Enhancement of the cauda equina and lumbosacral nerve roots is also documented.Reference Kastenbauer, Winkler, Fesl, Schiel, Ostermann and Yousry 8
Overall prognosis is guarded, with residual deficits including bowel/bladder dysfunction and ambulation difficulties. It is difficult to determine the contribution of steroids in neurological recovery.Reference Ibrahim, Elalamy, Doiphode, Mobyaed and Darweesh 3 , Reference Choudhary, Kumar, Ahlawat, Kapil, Yasir and Gaurav 5 - Reference Rathore, Gill and Malik 6 , Reference Kastenbauer, Winkler, Fesl, Schiel, Ostermann and Yousry 8 Since 1996, The Canadian Pediatric Surveillance Program has maintained a protocol to identify and investigate acute flaccid paralysis in children.Reference Desai 9 , 10
In our patient, CSF pleocytosis and biochemical analysis with positive Gram stain confirms an infectious etiology. Possibilities for cultures being negative include artifact on Gram stain or accumulation of the stain. Another possibility is that there was failure of the polymerase chain reaction because of a dead organism. Either direct infectious or infectious immune-mediated mechanisms are suspected for this diffuse myelitis. This rare presentation highlights considerations for an acute infectious diffuse myelopathy in patients that present with acute-onset progressive extremity weakness.
Disclosures
Ghita Ann Wiebe, Mubeen Rafay, Sergio Fanella, Jens Wrogemann, and Carrie Daymont have nothing to disclose.
There was no financial support or conflict of interest identified.